Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...
The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.
Clinical Trials Arena on MSN2d
MSD to push for approval of HIV combo after Phase III successMSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.
Long-Term Outcomes Reinforce the High Efficacy of Biktarvy ® in People with HIV and HBV Coinfection – – Investigational Long-Acting, Twice-Yearly Treatment Regimen of Len ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
An American biochemist whose research has helped scientists make inroads into treating coronavirus and HIV has won this ...
North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...
A research team led by UESTC has enhanced perovskite film stability using pyrrodiazole additives in inverted perovskite solar ...
The microbial fermentation technology market is experiencing significant growth, fueled by the increasing incidence of chronic diseases like cancer a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback